Graphpad renewal

The contract pertains to the renewal of a Graphpad agreement by the Food and Drug Administration (FDA). It is classified as a forecast contract under the NAICS code 511210, which typically involves software publishers and related services. Although specific solicitation details and set-aside types are not provided, the renewal indicates ongoing procurement activity related to Graphpad, likely a software or service essential for the FDA's operations. The contract was posted on March 11, 2026, and does not specify a particular location for performance. Contact points include a program liaison reachable via email at cderacquisitions@fda.hhs.gov and a contracting officer whose details are yet to be determined. This renewal signals the FDA's intent to continue utilizing Graphpad in support of its regulatory and research functions, reflecting the importance of maintaining critical software infrastructure within the agency.